Market announcement
AS PRFoods
LEI code
529900PFXFO2ZDCRNK93
Size of the entity
Medium group
Economic activities
Financial and Insurance Activities
Country of registered office
Estonia
General information
Categories
Management interim statement or quarterly financial report
Unique data record identifier
5801
Attachments
Submission date and time
18.11.2016 21:47:59
Content of announcement in Estonian
Title
PRF: AS-i PRFoods 2016. aasta 3. kvartali ja 9 kuu konsolideeritud auditeerimata vahearuanne
Message
Tallinn, Eesti, 2016-11-18 20:47 CET (GLOBE NEWSWIRE) --
Ülevaade majandustegevusest
Juhtkonna kommentaar
PRFoodsi 3. kvartal ja 9 kuud on olnud ettevõttele väga edukad kasumlikkuse
kasvatamisel tingituna kalakasvatuse väga headest tulemustest.
Kuigi 3. kvartali ja 9 kuu käive on langenud võrreldes eelmise aasta samade
perioodidega, on see kooskõlas ettevõtte eelarvega. 9 kuu käive oli kokku 30,5
miljonit eurot ja kogukäive langus oli 9 kuu baasil 7,8%. Käibe languse
põhjusteks on osade private label toodete äralangemine. Samas meie
ekspordikäive on kasvanud 9 kuuga 240%, ulatudes 1,7 miljoni euroni. Me loodame
kasvatada nii neljandas kvartalis kui järgmine aasta oluliselt just
ekspordikäivet.
Tingituna toorkala väga suurest hinnakasvust käesoleval aastal, mil hinnatõus
võrreldes eelmise aasta 9 kuuga on olnud vastavalt 47,5% lõhe ja 51,1%
vikerforelli puhul, on tooraine hinnatõus mõjutanud negatiivselt
brutokasumlikkust, mis 9 kuu baasil oli 6,8% ja 3 kuu baasil 4,7%. 4. kvartalis
on tavaliselt toimunud brutokasumi oluline kasv tingituna enda kasvatatud kala
suuremast kasutamisest tootmises.
Kalakasvatus on teinud rekordilisi tulemusi käesoleval aastal. Kalavarude
kogumaht on 9 kuuga 10,59 miljonit eurot ning tonnides 2 386. Kalavarude kasv
on 9 kuuga 256 tonni, ehk 12%. Keskmine kala hind on arvestuslikult 4,40 eurot
kilo oma kasvatustes. Rahalises väärtuses on kalavarude kasv olnud 3,4 miljonit
eurot.
EBITDA äritegevusest oli 9 kuu baasil -0,3 miljonit eurot (2015 aasta 9 kuud
1,5 miljonit eurot). EBITDA äritegevuse langus on tingitud tooraine
kallinemisest. 4. kvartalis, kui PRFoods kasutab omakasvatatud kala tootmises,
on oodata ka äritegevuse EBITDA kasvu tingituna asjaolust, et oma tooraine
omahind on maailmaturuhindadest odavam.
Konsolideeritud EBITDA koos kalakasvatustega oli 3. kvartalis 2,6 miljonit
eurot, kasv 147% ja 9 kuu konsolideeritud EBITDA oli 3,1 miljonit eurot, kasv
2,1 miljonit eurot.
Tegevuskulud on kontrolli all ja võrreldes eelmise aastaga on kulud vähenenud
8% ja ulatuvad 1,7 miljoni euroni. Töötajate arvu oleme mõnevõrra vähendanud,
211 töötaja asemel on 199 töötajat, tingituna efektiivsuse kasvust. Samas on
kogu palgafond samal tasemel, et maksta olemasolevale personalile paremat
töötasu.
Ettevõtte puhaskasum kasvas 3. kvartalis 1,6 miljoni euroni, kasv
võrdlusperioodiga 136%. 9 kuu baasil oli puhaskasum 1,2 miljonit eurot ja kasv
173%. Ettevõtte juhtkond on tulemustega väga rahul ning ootame 4. kvartali
positiivset kasvu.
3. kvartal 2016 võrreldes 2015. aasta 3. kvartali tulemusega
-- Auditeerimata konsolideeritud käive 10,5 miljonit eurot, kahanemine -7,3%
ehk -0,8 miljonit eurot.
-- Brutomarginaal 4,7%, kahanemine -9,7 protsendipunkti.
-- Bioloogiliste varade ümberhindluse positiivne mõju 2,9 miljonit eurot (2015
aasta 3. kvartal positiivne mõju 0,3 miljonit eurot).
-- EBITDA äritegevusest -0,3 miljonit eurot, halvenemine -1,0 miljonit eurot.
-- EBITDA 2,6 miljonit eurot, kasv 1,6 miljonit eurot ehk 147,3%.
-- Ärikasum 2,3 miljonit eurot, kasv 1,6 miljonit eurot ehk 202,2%.
-- Puhaskasum 1,6 miljonit eurot, kasv 0,9 miljonit eurot ehk 135,7%.
9 kuud 2016 võrreldes 2015. aasta 9 kuu tulemusega
-- Auditeerimata konsolideeritud käive 30,5 miljonit eurot, kahanemine -7,8%
ehk -2,6 miljonit eurot.
-- Brutomarginaal 6,8%, vähenemine -5,8 protsendipunkti.
-- Bioloogiliste varade ümberhindluse positiivne mõju 3,4 miljonit eurot (9
kuud 2015: negatiivne mõju -0,5 miljonit eurot).
-- EBITDA äritegevusest -0,3 miljonit eurot, halvenemine -1,8 miljonit eurot.
-- EBITDA 3,1 miljonit eurot, kasv 2,1 miljonit eurot.
-- Ärikasum 2,1 miljonit eurot, paranemine 2,0 miljonit eurot ehk 1 287,7%.
-- Puhaskasum 1,2 miljonit eurot, paranemine 0,8 miljonit eurot ehk 173,1%.
VÕTMENÄITAJAD
--------------------------------------------------------------------------------
Kasumiaruanne, 1kv 2kv 3kv 9k 1kv 2kv 3kv 9k
milj EUR 2016 2016 2016 2016 2015 2015 2015 2015
--------------------------------------------------------------------------------
Müügitulu 10,2 9,8 10,5 30,5 10,3 11,4 11,4 33,1
--------------------------------------------------------------------------------
Brutokasum 1,0 0,6 0,5 2,1 1,3 1,3 1,6 4,2
--------------------------------------------------------------------------------
EBITDA 0,2 -0,3 -0,3 -0,3 0,4 0,4 0,7 1,2
äritegevusest
--------------------------------------------------------------------------------
EBITDA -0,2 0,7 2,6 3,1 -0,6 0,6 1,1 0,7
--------------------------------------------------------------------------------
EBIT -0,5 0,3 2,3 2,1 -0,9 0,3 0,8 0,2
--------------------------------------------------------------------------------
EBT -0,6 0,2 2,2 1,9 -0,8 0,3 0,8 0,3
--------------------------------------------------------------------------------
Puhaskasum -0,5 0,04 1,6 1,2 -0,5 0,3 0,7 0,4
(-kahjum)
--------------------------------------------------------------------------------
Brutorentaablus 9,5% 6,3% 4,7% 6,8% 12,2% 11,3% 14,5% 12,6%
--------------------------------------------------------------------------------
Äritegevuse 2,1% -2,6% -2,6% -1,0% 4,1% 3,3% 6,5% 3,8%
EBITDA
marginaal
--------------------------------------------------------------------------------
EBITDA marginaal -2,2% 6,8% 24,9% 10,0% -5,9% 4,8% 9,4% 2,2%
--------------------------------------------------------------------------------
EBIT marginaal -5,2% 3,6% 22,0% 7,0% -8,6% 2,4% 6,8% 0,5%
--------------------------------------------------------------------------------
EBT marginaal -5,5% 2,3% 21,3% 6,2% -7,4% 2,9% 6,6% 0,9%
--------------------------------------------------------------------------------
Puhasrentaablus -4,5% 0,4% 15,5% 4,0% -5,2% 2,5% 6,1% 1,3%
--------------------------------------------------------------------------------
Tegevuskulude 10,5% 12,7% 11,2% 11,4% 11,3% 11,3% 11,9% 11,5%
suhtarv
--------------------------------------------------------------------------------
VÕTMEN
ÄITAJA
D
--------------------------------------------------------------------------------
----------
Bilans 31.03.2016 30.06.2016 30.09.2016 31.03.2015 30.06.2015 30.09.2015
31.12.2015
s,
milj
EUR
--------------------------------------------------------------------------------
----------
Netovõ -3,1 -1,4 1,3 -3,3 -6,5 -5,2
-0,6
lgnevu
s
--------------------------------------------------------------------------------
----------
Omakap 22,7 22,7 24,3 33,1 33,3 34,0
23,2
ital
--------------------------------------------------------------------------------
----------
Käibek 11,0 11,2 13,3 21,6 21,7 21,8
11,4
apital
--------------------------------------------------------------------------------
----------
Varad 28,6 29,3 34,4 39,5 39,4 40,1
29,5
--------------------------------------------------------------------------------
----------
Likvii 3,7 3,4 2,7 5,5 5,9 5,9
3,7
dsusko
rdaja
--------------------------------------------------------------------------------
----------
Omakap 79,4% 77,6% 70,7% 83,9% 84,6% 84,7%
78,8%
itali
suhta
rv
--------------------------------------------------------------------------------
----------
Finant -15,7% -6,7% 5,2% -11,0% -24,1% -18,2%
-2,5%
svõime
ndus
--------------------------------------------------------------------------------
----------
Netovõ -1,1 -0,7 1,2 -11,2 -8,2 -4,4
-0,2
lg/EBI
TDA
--------------------------------------------------------------------------------
----------
Omakap 4,5% 3,6% 6,7% -3,2% -3,9% -2,3%
4,1%
itali
tootl
us
--------------------------------------------------------------------------------
----------
Varade 3,7% 2,9% 5,2% -2,1% -2,6% -1,6%
3,4%
tootl
us
--------------------------------------------------------------------------------
----------
Konsolideeritud finantsseisundi aruanne
EUR '000 30.09.2016 30.09.2015 31.12.2015
-----------------------------------------------------------------------
VARAD
-----------------------------------------------------------------------
Raha ja ekvivalendid 3 551 6 054 1 921
-----------------------------------------------------------------------
Nõuded ja ettemaksed 2 543 7 050 3 653
-----------------------------------------------------------------------
Varud 4 205 5 940 5 616
-----------------------------------------------------------------------
Bioloogilised varad 10 591 7 247 4 421
-----------------------------------------------------------------------
Käibevara kokku 20 890 26 291 15 611
-----------------------------------------------------------------------
-----------------------------------------------------------------------
Edasilükkunud tulumaksuvara 134 103 138
-----------------------------------------------------------------------
Pikaajalised finantsinvesteeringud 103 161 161
-----------------------------------------------------------------------
Materiaalne põhivara 7 242 7 401 7 427
-----------------------------------------------------------------------
Immateriaalne vara 6 047 6 148 6 128
-----------------------------------------------------------------------
Põhivara kokku 13 526 13 813 13 854
-----------------------------------------------------------------------
VARAD KOKKU 34 416 40 104 29 465
-----------------------------------------------------------------------
-----------------------------------------------------------------------
KOHUSTUSED JA OMAKAPITAL
-----------------------------------------------------------------------
Võlakohustused 3 863 216 286
-----------------------------------------------------------------------
Võlad ja ettemaksed 3 509 4 057 3 760
-----------------------------------------------------------------------
Sihtfinantseerimine 244 180 177
-----------------------------------------------------------------------
Lühiajalised kohustused kokku 7 616 4 453 4 223
-----------------------------------------------------------------------
-----------------------------------------------------------------------
Võlakohustused 1 016 610 1 063
-----------------------------------------------------------------------
Edasilükkunud tulumaksukohustus 953 328 252
-----------------------------------------------------------------------
Sihtfinantseerimine 509 739 706
-----------------------------------------------------------------------
Pikaajalised kohustused kokku 2 478 1 677 2 021
-----------------------------------------------------------------------
KOHUSTUSED KOKKU 10 094 6 130 6 244
-----------------------------------------------------------------------
-----------------------------------------------------------------------
Aktsiakapital 7 737 19 342 7 737
-----------------------------------------------------------------------
Ülekurss 14 007 16 026 16 026
-----------------------------------------------------------------------
Oma aktsiad -227 -255 -172
-----------------------------------------------------------------------
Kohustuslik reservkapital 12 6 6
-----------------------------------------------------------------------
Realiseerimata kursivahed 420 439 471
-----------------------------------------------------------------------
Jaotamata kasum (-kahjum) 2 373 -1 584 -847
-----------------------------------------------------------------------
Ettevõtte aktsionäridele kuuluv osa 24 322 33 974 23 221
-----------------------------------------------------------------------
OMAKAPITAL KOKKU 24 322 33 974 23 221
-----------------------------------------------------------------------
OMAKAPITAL JA KOHUSTUSED KOKKU 34 416 40 104 29 465
-----------------------------------------------------------------------
Konsolideeritud koondkasumiaruanne
EUR '000 3kv 3kv 9k 2016 9k 2015 12k
2016 2015 2015
--------------------------------------------------------------------------------
Müügitulud 10 530 11 358 30 526 33 095 50 273
--------------------------------------------------------------------------------
Müüdud kaupade kulu -10 034 -9 716 -28 438 -28 910 -43 509
--------------------------------------------------------------------------------
Brutokasum 496 1 642 2 088 4 185 6 764
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Tegevuskulud -1 175 -1 353 -3 488 -3 812 -5 411
--------------------------------------------------------------------------------
Turundus- ja müügikulud -827 -992 -2 382 -2 784 -4 033
--------------------------------------------------------------------------------
Üldhalduskulud -348 -361 -1 106 -1 028 -1 378
--------------------------------------------------------------------------------
Muud äritulud/-kulud 102 159 173 310 406
--------------------------------------------------------------------------------
Bioloogiliste varade ümberhindlus 2 898 320 3 364 -529 -888
--------------------------------------------------------------------------------
Ärikasum (-kahjum) 2 321 768 2 137 154 871
--------------------------------------------------------------------------------
Finantstulud 0 9 1 238 303
--------------------------------------------------------------------------------
Finantskulud -76 -24 -231 -80 -105
--------------------------------------------------------------------------------
Maksustamiseelne kasum (-kahjum) 2 245 753 1 907 312 1 069
--------------------------------------------------------------------------------
Tulumaks -616 -62 -700 130 110
--------------------------------------------------------------------------------
Aruandeperioodi puhaskasum (-kahjum) 1 629 691 1 207 442 1 179
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Muu koondkasum (-kahjum), mida võib
hiljem klassifitseerida
kasumiaruandesse:
--------------------------------------------------------------------------------
Valuutakursi vahed -21 -27 -51 -2 30
--------------------------------------------------------------------------------
Kokku koondkasum (-kahjum) 1 608 664 1 156 440 1 209
--------------------------------------------------------------------------------
Indrek Kasela
AS PRFoods
Juhatuse liige
T: +372 6033 800
[email protected]
www.prfoods.ee
Content of announcement in English
Title
PRF: Consolidated Unaudited Interim Report of AS PRFoods for 3rd quarter and 9 months of 2016
Message
Tallinn, Estonia, 2016-11-18 20:47 CET (GLOBE NEWSWIRE) --
Overview of the economic activities
Management commentary
3rd quarter and 9 months have been very successful for PRFoods in terms of
profitability, caused by very good results from fish farming.
Although the revenues of 3rd quarter and 9 months are lower on year-on-year
basis, it follows the revenues forecast. 9 months sales were 30.5 million euros
and the total decrease in sales in 9 months was 7.8%. The main reasons behind
decrease in sales is discontinuation of certain private label products. At the
same time our export has grown by 240%, reaching 1.7 million euros. We believe
that 4th quarter and next year will bring further growth in export sales.
Due to the rapid increase in raw material prices, whereby the increase on
yearly basis of salmon has been 47.5% and rainbow trout 51.1%, the gross
margins of the company have decreased to 6.8% on 9 months basis and 4.7% in 3rd
quarter. Usually we witness increase in gross margins during 4th quarter as we
process more of own farmed fish in production and rely less on world markets.
Fish farming has set new records this year. The total biomass is 10,59 million
euros and 2,386 tons on 9 months basis. The growth of biomass in 9 months was
256 tons and 12%. The average price of fish in farms is 4.40 euros per kilo. In
monetary terms the biomass revaluation produced 3.4 million euros profit.
EBITDA form operations on 9 months basis was -0.3 million (2015 year 9 months
was 1.5 million euros). The decrease in EBITDA from operations is caused by
more expensive raw materials. In 4th quarter PRFoods expects a growth in EBITDA
from operations as we start processing own farmed fish, which is cheaper than
world market prices.
Consolidated EBITDA together with fish farming in 3rd quarter was 2.6 million
euros, increase of 147% and 9 months consolidated EBITDA is 3.1 million euros,
growing by 2.1 million euros in comparison period.
Operating costs have remained under control and we decreased the costs by 8%
over comparison period, down to 1.7 million euros. The number of employees has
decreased from 211 to 199 due to higher efficiencies in productions. Payroll
has remained the same as to compensate the existing staff better.
Net profit increased in 3rd quarter to 1.6 million euros, growth of 136% during
comparison period. On 9 months basis, the net profit is 1.2 million euros,
growing by 173%. The management of the company is very pleased with the results
of 9 months and has positive outlook for 4th quarter.
The 3rd quarter of 2016 compared to the 3rd quarter of 2015
-- Unaudited consolidated revenue 10.5 million euros, decrease -0.8 million
euros, i.e. -7.3%.
-- Gross margin 4.7%, decrease -9.7 percentage points.
-- Positive impact from revaluation of biological assets 2.9 million euros
(3rd quarter 2015: positive impact of
0.3 million euros).
-- EBITDA from operations -0.3 million euros, decrease -1.0 million euros.
-- EBITDA 2.6 million euros, improvement 1.6 million euros, i.e. 147.3%.
-- The operating profit 2.3 million euros, improvement 1.6 million euros, i.e.
202.2%.
-- Net profit 1.6 million euros, improvement 0.9 million euros, i.e. 135.7%.
9months of 2016 compared to 9 months of 2015
-- Unaudited consolidated revenue 30.5 million euros, decrease -2.6 million
euros, i.e. -7.8%.
Gross margin 6.8%, decrease -5.8 percentage points.
-- Positive impact from revaluation of biological assets 3.4 million euros (9
months 2015: negative impact of
-0.5 million euros).
-- EBITDA from operations -0.3 million euros, decrease -1.8 million euros.
-- EBITDA 3.1 million euros, improvement 2.1 million euros.
-- The operating profit 2.1 million euros, improvement 2.0 million euros, i.e.
1,287.7%.
-- Net profit 1.2 million euros, improvement 0.8 million euros, i.e. 173.1%.
KEY RATIOS
--------------------------------------------------------------------------------
Income Q1 Q2 Q3 9m Q1 Q2 Q3 9m
Statement, EUR 2016 2016 2016 2016 2015 2015 2015 2015
mln
--------------------------------------------------------------------------------
Sales 10.2 9.8 10.5 30.5 10.3 11.4 11.4 33.1
--------------------------------------------------------------------------------
Gross profit 1.0 0.6 0.5 2.1 1.3 1.3 1.6 4.2
--------------------------------------------------------------------------------
EBITDA from 0.2 -0.3 -0.3 -0.30 0.4 0.4 0.7 1.2
operations
--------------------------------------------------------------------------------
EBITDA -0.2 0.7 2.6 3.1 -0.6 0.6 1.1 0.7
--------------------------------------------------------------------------------
EBIT -0.5 0.3 2.3 2.1 -0.9 0.3 0.8 0.2
--------------------------------------------------------------------------------
EBT -0.6 0.2 2.2 1.9 -0.8 0.3 0.8 0.3
--------------------------------------------------------------------------------
Net profit -0.5 0.04 1.6 1.2 -0.5 0.3 0.7 0.4
(-loss)
--------------------------------------------------------------------------------
Gross margin 9.5% 6.3% 4.7% 6.8% 12.2% 11.3% 14.5% 12.6%
--------------------------------------------------------------------------------
Operational 2.1% -2.6% -2.6% -1.0% 4.1% 3.3% 6.5% 3.8%
EBITDA margin
--------------------------------------------------------------------------------
EBITDA margin -2.2% 6.8% 24.9% 10.0% -5.9% 4.8% 9.4% 2.2%
--------------------------------------------------------------------------------
EBIT margin -5.2% 3.6% 22.0% 7.0% -8.6% 2.4% 6.8% 0.5%
--------------------------------------------------------------------------------
EBT margin -5.5% 2.3% 21.3% 6.2% -7.4% 2.9% 6.6% 0.9%
--------------------------------------------------------------------------------
Net margin -4.5% 0.4% 15.5% 4.0% -5.2% 2.5% 6.1% 1.3%
--------------------------------------------------------------------------------
Operating 10.5% 12.7% 11.2% 11.4% 11.3% 11.3% 11.9% 11.5%
expense ratio
--------------------------------------------------------------------------------
KEY
RATIO
S
--------------------------------------------------------------------------------
----------
Balanc 31/03/2016 30/06/2016 30/09/2016 31/03/2015 30/06/2015 30/09/2015
31/12/2015
e
Sheet
, EUR
mln
--------------------------------------------------------------------------------
----------
Net -3.1 -1.4 1.3 -3.3 -6.5 -5.2
-0.6
debt
--------------------------------------------------------------------------------
----------
Equity 22.7 22.7 24.3 33.1 33.3 34.0
23.2
--------------------------------------------------------------------------------
----------
Workin 11.0 11.2 13.3 21.6 21.7 21.8
11.4
g
capit
al
--------------------------------------------------------------------------------
----------
Assets 28.6 29.3 34.4 39.5 39.4 40.1
29.5
--------------------------------------------------------------------------------
----------
Liquid 3.7 3.4 2.7 5.5 5.9 5.9
3.7
ity
ratio
--------------------------------------------------------------------------------
----------
Equity 79.4% 77.6% 70.7% 83.9% 84.6% 84.7%
78.8%
ratio
--------------------------------------------------------------------------------
----------
Gearin -15.7% -6.7% 5.2% -11.0% -24.1% -18.2%
-2.5%
g
ratio
--------------------------------------------------------------------------------
----------
Net -1.1 -0.7 1.2 -11.2 -8.2 -4.4
-0.2
debt-
to-EBI
TDA
--------------------------------------------------------------------------------
----------
ROE 4.5% 3.6% 6.7% -3.2% -3.9% -2.3%
4.1%
--------------------------------------------------------------------------------
----------
ROA 3.7% 2.9% 5.2% -2.1% -2.6% -1.6%
3.4%
--------------------------------------------------------------------------------
----------
Consolidated statement of financial position
EUR '000 30/09/2016 30/09/2015 31/12/2015
-------------------------------------------------------------------
ASSETS
-------------------------------------------------------------------
Cash and cash equivalents 3,551 6,054 1,921
-------------------------------------------------------------------
Receivables and prepayments 2,543 7,050 3,653
-------------------------------------------------------------------
Inventories 4,205 5,940 5,616
-------------------------------------------------------------------
Biological assets 10,591 7,247 4,421
-------------------------------------------------------------------
Total current assets 20,890 26,291 15,611
-------------------------------------------------------------------
-------------------------------------------------------------------
Deferred income tax 134 103 138
-------------------------------------------------------------------
Long-term financial investments 103 161 161
-------------------------------------------------------------------
Tangible fixed assets 7,242 7,401 7,427
-------------------------------------------------------------------
Intangible assets 6,047 6,148 6,128
-------------------------------------------------------------------
Total non-current assets 13,526 13,813 13,854
-------------------------------------------------------------------
TOTAL ASSETS 34,416 40,104 29,465
-------------------------------------------------------------------
-------------------------------------------------------------------
EQUITY AND LIABILITIES
-------------------------------------------------------------------
Loans and borrowings 3,863 216 286
-------------------------------------------------------------------
Payables 3,509 4,057 3,760
-------------------------------------------------------------------
Government grants 244 180 177
-------------------------------------------------------------------
Total current liabilities 7,616 4,453 4,223
-------------------------------------------------------------------
-------------------------------------------------------------------
Loans and borrowings 1,016 610 1,063
-------------------------------------------------------------------
Deferred tax liabilities 953 328 252
-------------------------------------------------------------------
Government grants 509 739 706
-------------------------------------------------------------------
Total non-current liabilities 2,478 1,677 2,021
-------------------------------------------------------------------
TOTAL LIABILITIES 10,094 6,130 6,244
-------------------------------------------------------------------
-------------------------------------------------------------------
Share capital 7,737 19,342 7,737
-------------------------------------------------------------------
Share premium 14,007 16,026 16,026
-------------------------------------------------------------------
Treasury shares -227 -255 -172
-------------------------------------------------------------------
Statutory capital reserve 12 6 6
-------------------------------------------------------------------
Currency translation reserve 420 439 471
-------------------------------------------------------------------
Retained profit (-loss) 2,373 -1,584 -847
-------------------------------------------------------------------
Equity attributable to parent 24,322 33,974 23,221
-------------------------------------------------------------------
TOTAL EQUITY 24,322 33,974 23,221
-------------------------------------------------------------------
TOTAL EQUITY AND LIABILITIES 34,416 40,104 29,465
-------------------------------------------------------------------
Consolidated statement of profit or loss and other comprehensive income
EUR '000 Q3 2016 Q3 9m 2016 9m 2015 12m
2015 2015
--------------------------------------------------------------------------------
Sales 10,530 11,358 30,526 33,095 50,273
--------------------------------------------------------------------------------
Cost of goods sold -10,034 -9,716 -28,438 -28,910 -43,509
--------------------------------------------------------------------------------
Gross profit 496 1,642 2,088 4,185 6,764
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Operating expenses -1,175 -1,353 -3,488 -3,812 -5,411
--------------------------------------------------------------------------------
Selling and distribution expenses -827 -992 -2,382 -2,784 -4,033
--------------------------------------------------------------------------------
Administrative expenses -348 -361 -1,106 -1,028 -1,378
--------------------------------------------------------------------------------
Other income/expenses 102 159 173 310 406
--------------------------------------------------------------------------------
Fair value adjustment on biological 2,898 320 3,364 -529 -888
assets
--------------------------------------------------------------------------------
Operating profit (-loss) 2,321 768 2,137 154 871
--------------------------------------------------------------------------------
Financial income 0 9 1 238 303
--------------------------------------------------------------------------------
Financial expenses -76 -24 -231 -80 -105
--------------------------------------------------------------------------------
Profit (-loss) before tax 2,245 753 1,907 312 1,069
--------------------------------------------------------------------------------
Income tax -616 -62 -700 130 110
--------------------------------------------------------------------------------
Net profit (-loss) for the period 1,629 691 1,207 442 1,179
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Other comprehensive income (-loss)
that may subsequently be classified
to profit or loss:
--------------------------------------------------------------------------------
Foreign currency translation -21 -27 -51 -2 30
differences
--------------------------------------------------------------------------------
Total comprehensive income 1,608 664 1,156 440 1,209
(-expense)
--------------------------------------------------------------------------------
Indrek Kasela
AS PRFoods
Member of the Management Board
Phone: +372 6033 800
[email protected]
www.prfoods.ee